首页   按字顺浏览 期刊浏览 卷期浏览 Nafarelin in the Treatment of Endometriosis
Nafarelin in the Treatment of Endometriosis

 

作者: Magdalen E. Hull,   Robert L. Barbieri,  

 

期刊: Gynecologic and Obstetric Investigation  （Karger Available online 1994）
卷期: Volume 37, issue 4  

页码: 263-264

 

ISSN:0378-7346

 

年代: 1994

 

DOI:10.1159/000292574

 

出版商: S. Karger AG

 

关键词: Endometriosis;Nafarelin;Dose management

 

数据来源: Karger

 

摘要:

Nafarelin, a gonadotropin-releasing hormone agonist, has been shown to be effective in the treatment of endometriosis. The standard dosage is 200 µg bid intranasally. Side effects most commonly include those associated with estrogen deprivation. By assessing estrogen status, the standard dosage can be manipulated to minimize these side effects and increase patient compliance

 

点击下载:  PDF (989KB)



返 回